EBO Ebos Group Ltd
- 31.510
- +0.140+0.45%
Ebos Group Ltd News
Jarden Securities Upgrades Ebos Group to Overweight From Neutral, Price Target Is NZ$38.00
Ebos Group (NZE:EBO) has an average rating of hold and price targets ranging from NZ$30.50 to NZ$40.93, according to analysts polled by CapitalIQ.
Ebos Group Appoints New CFO
Ebos Group (NZE:EBO, ASX:EBO) has appointed Alistair Gray as chief financial officer effective Sept. 30, according to a Friday New Zealand bourse filing. The Australasian healthcare, medical and pharm
AU Evening Wrap: Australia Shares Slip 0.1% on Large-Cap Weakness
All five of the country's largest banks finished lower.
Ebos Group Declares DRP Strike Price for Interim Dividend
Healthcare products distributor Ebos Group (ASX:EBO, NZE:EBO) declared a strike price of NZ$35.65 per share for the shares to be issued under the dividend reinvestment plan (DRP) for its half-year div
Ebos Can Weather Loss of Chemist Warehouse Contract -- Market Talk
2339 GMT - Forsyth Barr says it's more confident that Ebos can navigate the loss of a big contract with Chemist Warehouse without significant downside to current FY 2025 consensus expectations. Repres
Morgan Stanley Adjusts EBOS Group's Price Target to AU$37 From AU$38, Keeps at Overweight
09:25 PM EST, 03/05/2024 (MT Newswires) -- Morgan Stanley Adjusts EBOS Group's Price Target to AU$37 From AU$38, Keeps at Overweight Price (AUD): $33.90, Change: $-0.43, Percent Change: -1.25%
Ebos Target Price Raised 3.8% to NZ$40.70/Share by Macquarie>EBO.NZ
Ebos Target Price Raised 3.8% to NZ$40.70/Share by Macquarie>EBO.NZ
Ebos Price Target Cut 0.6% to A$39.20/Share by Morgans
Ebos Price Target Cut 0.6% to A$39.20/Share by Morgans
EBOS Posts Half Year FY24 Revenue Up 7% to AU$6.58 Million; Underlying EPS of AU$0.795
03:36 PM EST, 02/20/2024 (MT Newswires) -- EBOS Posts Half Year FY24 Revenue Up 7% to AU$6.58 Million; Underlying EPS of AU$0.795 Price (AUD): $34.28, Change: $+0.67, Percent Change: +1.99%
Ebos 1H Net Profit A$152.4M
Ebos 1H Net Profit A$152.4M
Ebos Target Price Raised 1.8% to NZ$39.20/Share by Macquarie>EBO.NZ
Ebos Target Price Raised 1.8% to NZ$39.20/Share by Macquarie>EBO.NZ
Medicare Levy Change: 1.2 Million Aussies to Get Extra Tax Boost
Millions of Aussies will be able to avoid or pay a lower Medicare levy under a major change announced by the government.
Australia's Q4 Inflation Rate Eases to 0.6%, Falling Below Expectations
The CPI slowed to 0.6% in the December quarter, down from 1.2% in the previous quarter. Market consensus was 0.8%.
Australian Inflation Slows in November to 4.3%, Below Forecast
The headline consumer price index increased by 4.3% over the 12 months to November, down from 4.9% in October. This figure came in just below the market forecast of 4.4%.
When Can ASX 200 Investors Expect RBA Interest Rate Cuts?
Will interest rates go higher yet from here? Or can ASX 200 investors look forward to some rate-cutting relief from the RBA in 2024?
New Zealand Shares Rise on Tuesday on Upbeat Economic Data; EBOS Raises Ownership in Transmedic to 90%
New Zealand shares rose on Tuesday as investor sentiment was lifted by positive economic data. The S&P/NZ50 Index rose 0.45%, or 52.39 points, to close at 11,617.37. New Zealand business confidence ro
Ebos Agrees Option to Buy Remaining 10% of Transmedic After Two Years
Ebos Agrees Option to Buy Remaining 10% of Transmedic After Two Years
Ebos Funds Purchase of Additional Stake in Transmedic From Existing Debt Facilities
Ebos Funds Purchase of Additional Stake in Transmedic From Existing Debt Facilities
Ebos Pays SGD119 Million For Additional Stake in Transmedic
Ebos Pays SGD119 Million For Additional Stake in Transmedic
Ebos Raises Stake in Transmedic to 90% From 51%
Ebos Raises Stake in Transmedic to 90% From 51%
Analysis
Price Target
No Data
